In certain embodiments APP-specific BACE inhibitors (ASBIs) are provided as well as uses thereof. In certain embodiments methods of preventing or delaying the onset of a pre-Alzheimer' s condition and/or cognitive dysfunction, and/or ameliorating one or more symptoms of a pre-Alzheimer' s condition and/or cognitive dysfunction, or preventing or delaying the progression of a pre-Alzheimer' s condition or cognitive dysfunction to Alzheimer' s disease are provided where the method involves administering to a subject in need thereof an APP specific BACE inhibitor (ASBI) in an amount sufficient to prevent or delay the onset of a pre-Alzheimer' s cognitive dysfunction, and/or to ameliorate one or more symptoms of a pre-Alzheimer' s cognitive dysfunction, and/or to prevent or delay the progression of a pre-Alzheimer' s cognitive dysfunction to Alzheimer' s disease. In certain embodiments the ASBI is a flavonoid (e.g. galangin) or flavonoid progrug (e.g., galangin prodrug).